Genomma Lab Internacional SAB De CV (LABB)

Mexico
21.00
+0.68(+3.36%)
  • Volume:
    2,613,521
  • Bid/Ask:
    20.80/20.90
  • Day's Range:
    19.93 - 21.20

LABB Overview

Prev. Close
20.22
Day's Range
19.93-21.2
Revenue
14.08B
Open
20.26
52 wk Range
18.3-24.58
EPS
1.42
Volume
2,613,521
Market Cap
21.21B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,829,307
P/E Ratio
14.83
Beta
0.52
1-Year Change
5.16%
Shares Outstanding
1,010,011,422
Next Earnings Date
Jul 28, 2021
What is your sentiment on Genomma Lab Internacional SAB De CV?
or
Market is currently closed. Voting is open during market hours.

Genomma Lab Internacional SAB De CV News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Genomma Lab Internacional SAB De CV Company Profile

Genomma Lab Internacional SAB De CV Company Profile

Employees
1310
Market
Mexico

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Read More
  • trash company
    0
    • Large
      0
      • Great rentability in 2019. hope it gets the same this year
        0
        • Downtrend triangle at 11.800
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.